Renske Altena - Department of Oncology and Pathology, Karolinska Institutet

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 54 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Affibody PET Imaging of HER2-Expressing Cancers As a Key to Guide HER2-Targeted Therapy

Nina Eissler,Renske Altena,Ali Alhuseinalkhudhur,Olga Bragina,Joachim Feldwisch, Guido Wuerth,Annika Loftenius,Nikolai Brun,Rimma Axelsson,Vladimir Tolmachev,Jens Sörensen,Fredrik Y Frejd

Biomedicinesno. 5 (2024): 1088

引用0浏览0WOS引用

Tackling Hurdles in Front of Young Clinical Investigators in Oncology – Results from an International Survey

Mariela Vasileva-Slaveva, Daniela Morales-Espinosa, Alberto Puccini,Magdalena Meissner, Marina Milic,Giuseppe Lamberti,Renske Altena

European Journal of Surgical Oncologyno. 6 (2024): 108031-108031

引用0浏览0WOS引用

Physical Exercise During Neoadjuvant Chemotherapy for Breast Cancer As a Mean to Increase Pathological Complete Response Rates: Trial Protocol of the Randomized Neo-ACT Trial

Jana de Boniface,Cecilia Haddad Ringborg,Renske Altena,Yvonne Wengstrom

CANCER RESEARCHno. 9 (2024)

引用1浏览0WOS引用

435Tip Molecular Imaging of Programmed Death Ligand 1 (PD-L1) Expression with [89Zr]zr-Atezolizumab Positron Emission Tomography/computed Tomography (PET/CT) in Patients with Metastatic Triple Negative Breast Cancer (mtnbc): the MIMIR-study

R. Altena, A. Tzortzakakis, A. Blomgren, E. Jussing, S. Ekman, T. Tran, R. Axelsson, J. Bergh

Annals of Oncology (2024)

引用0浏览0引用

Supervised, Structured and Individualized Exercise in Metastatic Breast Cancer: a Randomized Controlled Trial

Nature medicineno. 10 (2024): 2957-2966

引用0浏览0WOSNATURE引用

Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga]ga-Aby-025: Results from a Pilot Study

Renske Altena,Siri af Buren,August Blomgren,Emelie Karlsson,Antonios Tzortzakakis,Nikolai Brun,Mohammad M. Moein,Emma Jussing,Fredrik Y. Frejd,Jonas Bergh,Thuy A. Tran,Johan Hartman,Rimma Axelsson

JOURNAL OF NUCLEAR MEDICINEno. 5 (2024): 700-707

引用0浏览0WOS引用

[Molecular Diagnostics Enable Targeted Therapies for Anaplastic and Poorly Differentiated Thyroid Cancer]

Renske Altena, Mikael Nilsson, Viveka Bergman,Jakob Dahlberg,Carl Christofer Juhlin,Jan Zedenius

Lakartidningen (2024)

引用0浏览0WOS引用

Molecular PD-L1 PET/CT Imaging with 89Zr-atezolizumab to Monitor Immune Responses in metastatic Triple Negative Breast Cancer: study protocol for a phase II diagnostic imaging trial

Renske Altena,Thuy A. Tran,Una Kjällquist,Mattias Karlsson,Jonathan Siikanen,Emma Jussing,Antonios Tzortzakakis,Olof Jonmarker,Rimma Axelsson,Jonas Bergh

medrxiv（2023）

引用0浏览0引用

Preclinical evaluation of [⁸⁹Zr]Zr-DFO*-sacituzumab, a PET tracer for imaging of whole body TROP-2 expression as a potential selection tool for treatment with TROP-2 antibody drug conjugates (ADC)

Klas Bratteby,Lidija Smertinaite, Samar Omer, Li Lu,Stefan Milton,Emma Jussing,Jonathan Siikanen,Erik Samen,Rimma Axelsson,Theodoros Foukakis,Renske Altena,Thuy Tran

Nuclear Medicine and Biology (2023): S46-S46

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn